WLSI Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
WLSI FAQ
What was Wellstar International Inc.’s price range in the past 12 months?
Currently, no data Available
What is Wellstar International Inc.’s market cap?
Wellstar International Inc.’s market cap is $7.37K.
When is Wellstar International Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Wellstar International Inc.’s earnings last quarter?
Currently, no data Available
Is Wellstar International Inc. overvalued?
According to Wall Street analysts Wellstar International Inc.’s price is currently Overvalued.
Does Wellstar International Inc. pay dividends?
Wellstar International Inc. does not currently pay dividends.
What is Wellstar International Inc.’s EPS estimate?
Wellstar International Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wellstar International Inc. have?
Wellstar International Inc. has 7,371,327,600 shares outstanding.
What happened to Wellstar International Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Wellstar International Inc.?
Currently, no hedge funds are holding shares in WLSI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Wellstar International Inc.
Wellstar International, Inc. currently engages in very limited business activities. In its past operations, the company, through its subsidiary, Trillennium Medical Imaging, Inc., concentrated on creating and licensing advanced thermal imaging solutions for various consumer healthcare needs. This sophisticated technology provided diagnostic screening for the early detection of breast cancer. Additionally, it assisted in distinguishing between different pain conditions, including reflex sympathetic dystrophy, neuromusculoskeletal syndromes, and other neurological disorders. The technology was also utilized for identifying pressure ulcers, deep tissue damage, and bedsores, alongside its uses in orthopedic applications. Founded in 1997, Wellstar International, Inc. is headquartered in Holland, Ohio.
Scinai Immunotherapeutics
―
Aditxt
―
PainReform
―
NewcelX
―
Virax Biolabs Group Ltd. Class A
―